Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system
- PMID:6444721
- PMCID: PMC348208
- DOI: 10.1073/pnas.77.1.62
Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system
Abstract
The existence of a five-membered isozyme system for human phosphofructokinase (PFK; ATP:D-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11) has been demonstrated. These multimolecular forms result from the random polymerization of two distinct subunits, M (muscle type) and L (liver type), to form all possible tetrameters-i.e., M(4), M(3)L, M(2)L(2), ML(3), and L(4). Partially purified muscle and liver PFKs were hybridized by dissociation at low pH and then recombination at neutrality. Three hybrid species were generated in addition to the two parental isozymes, to yield an entire five-membered set. The various species could be consistently and reproducibly separated from one another by DEAE-Sephadex chromatography at pH 8.0 with a concave elution gradient of salt. Under similar experimental conditions, erythrocyte PFK from hemolysates was also resolved into five species chromatographically indistinguishable from those produced in the above experiment. Immunological and kinetic studies of the isozymes provided corroborative evidence to support the proposed subunit structures. Erythrocyte PFK was found to have kinetic properties intermediate between those of muscle and liver PFK and was neutralized only 50% by an antiserum against muscle PFK that completely neutralized muscle PFK. These data demonstrate that muscle and liver PFKs are distinct homotetramers-i.e., M(4) and L(4), respectively-whereas erythrocyte PFK is a heterogeneous mixture of all five isozymes. The structural heterogeneity of erythrocyte PFK provides a molecular genetic basis for the differential organ involvement observed in some inherited PFK deficiency states in which myopathy or hemolysis or both can occur.
Similar articles
- Characterization of the enzymatic lesion in inherited phosphofructokinase deficiency in the dog: an animal analogue of human glycogen storage disease type VII.Vora S, Giger U, Turchen S, Harvey JW.Vora S, et al.Proc Natl Acad Sci U S A. 1985 Dec;82(23):8109-13. doi: 10.1073/pnas.82.23.8109.Proc Natl Acad Sci U S A. 1985.PMID:2933748Free PMC article.
- Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies.Vora S, Oskam R, Staal GE.Vora S, et al.Biochem J. 1985 Jul 15;229(2):333-41. doi: 10.1042/bj2290333.Biochem J. 1985.PMID:2931076Free PMC article.
- Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency.Vora S, Davidson M, Seaman C, Miranda AF, Noble NA, Tanaka KR, Frenkel EP, Dimauro S.Vora S, et al.J Clin Invest. 1983 Dec;72(6):1995-2006. doi: 10.1172/JCI111164.J Clin Invest. 1983.PMID:6227635Free PMC article.
- [Phosphofructokinase (PFK)].Nakajima H.Nakajima H.Nihon Rinsho. 1995 May;53(5):1241-6.Nihon Rinsho. 1995.PMID:7602786Review.Japanese.
- A review of animal phosphofructokinase isozymes with an emphasis on their physiological role.Dunaway GA.Dunaway GA.Mol Cell Biochem. 1983;52(1):75-91. doi: 10.1007/BF00230589.Mol Cell Biochem. 1983.PMID:6306441Review.
Cited by
- Exploiting unique structural and functional properties of malarial glycolytic enzymes for antimalarial drug development.Alam A, Neyaz MK, Ikramul Hasan S.Alam A, et al.Malar Res Treat. 2014;2014:451065. doi: 10.1155/2014/451065. Epub 2014 Dec 17.Malar Res Treat. 2014.PMID:25580350Free PMC article.Review.
- Characterization of the enzymatic lesion in inherited phosphofructokinase deficiency in the dog: an animal analogue of human glycogen storage disease type VII.Vora S, Giger U, Turchen S, Harvey JW.Vora S, et al.Proc Natl Acad Sci U S A. 1985 Dec;82(23):8109-13. doi: 10.1073/pnas.82.23.8109.Proc Natl Acad Sci U S A. 1985.PMID:2933748Free PMC article.
- Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis.García M, Pujol A, Ruzo A, Riu E, Ruberte J, Arbós A, Serafín A, Albella B, Felíu JE, Bosch F.García M, et al.PLoS Genet. 2009 Aug;5(8):e1000615. doi: 10.1371/journal.pgen.1000615. Epub 2009 Aug 21.PLoS Genet. 2009.PMID:19696889Free PMC article.
- Assignment of the human gene for liver-type 6-phosphofructokinase isozyme (PFKL) to chromosome 21 by using somatic cell hybrids and monoclonal anti-L antibody.Vora S, Francke U.Vora S, et al.Proc Natl Acad Sci U S A. 1981 Jun;78(6):3738-42. doi: 10.1073/pnas.78.6.3738.Proc Natl Acad Sci U S A. 1981.PMID:6455664Free PMC article.
- Physiological relevance of the changing subunit composition and regulatory properties of the 6-phosphofructo-1-kinase isozyme pools during heart and muscle development.Dunaway GA, Kasten TP.Dunaway GA, et al.Mol Cell Biochem. 1989 May 4;87(1):71-7. doi: 10.1007/BF00421084.Mol Cell Biochem. 1989.PMID:2549392
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Molecular Biology Databases